Cancer Control

Papers
(The H4-Index of Cancer Control is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look51
Recent Estimates and Predictions of 5-Year Survival in Patients with Gastric Cancer: A Model-Based Period Analysis42
Quantitative imaging decision support (QIDSTM) tool consistency evaluation and radiomic analysis by means of 594 metrics in lung carcinoma on chest CT scan42
Risk Factors for the Diagnosis of Colorectal Cancer41
Factors Explaining Socio-Economic Inequalities in Cancer Survival: A Systematic Review35
Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients28
The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature Review27
Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy26
Knowledge, Attitude, and Practice on Cervical Cancer and Screening Among Women in India: A Review22
The Effects of COVID-19 on Cancer Care Provision: A Systematic Review22
Cancer Incidence and Mortality in Asian Countries: A Trend Analysis20
Health-Related Quality of Life in Asian Differentiated Thyroid Cancer Survivors18
Nimotuzumab, an Anti-EGFR Monoclonal Antibody, in the Treatment of Nasopharyngeal Carcinoma17
Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer17
Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody16
Feature Selection is Critical for 2-Year Prognosis in Advanced Stage High Grade Serous Ovarian Cancer by Using Machine Learning16
0.041613817214966